Linda F. Carson

Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

Maurie Markman, Brian N. Bundy, David S. Alberts et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Melissa A. Geller, Sarah Cooley, Patricia L. Judson et al. · Cytotherapy · 2010 · 426 citations · Full text

Breast Oncology, Medicine, Immunology +10

Vascular endothelial growth factor expression in early stage ovarian carcinoma

Pamela J. Paley, Katherine Staskus, Kristin Gebhard et al. · Cancer · 1997 · 370 citations · Full text

Vascular permeability factor gene expression in normal and neoplastic human ovaries.

T. A. Olson, D. Mohanraj, Linda F. Carson et al. · PubMed · 1994 · 256 citations

Epithelial Ovarian Cancer, Pathology, Tumor Biology +16

Pretreatment surgical staging of patients with cervical carcinoma

Jonathan A. Cosin, Jeffrey M. Fowler, M. Dwight Chen et al. · Cancer · 1998 · 234 citations · Full text